We rank companies based on fund manager, research analyst and news sentiment
GUTS

Fractyl Health
GUTS

$6.64
4.69%
 

About: Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Employees: 84

Funds holding %
of 6,474 funds
Analysts bullish %
0
News positive %
of 4 articles

Fund manager confidence

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$18
171%
upside
Avg. target
$18
171%
upside
High target
$18
171%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Morgan Stanley
Michael Ulz
171%upside
$18
Overweight
Initiated
27 Feb 2024

Financial journalist opinion

Based on 4 articles about GUTS published over the past 30 days